In this video, I use a genetic algorithm to train an AI to navigate more levels of the world's hardest game. Check out the ...

Vgenomics offers RgenX, an AI-powered cloud platform that diagnoses rare genetic diseases and accelerates drug discovery by ...

InvestorAi's AI models empower retail investors with outperforming equity baskets, leveraging proprietary tech. CEO Bruce Keith discusses the company's growth and future plans.

Key market opportunities in the AI-powered rare disease diagnosis domain include leveraging AI for personalized medicine, ...

The AI microscopy market is driven by personalized medicine, precision therapy demand, and real-time image advancements.

In interviews with The Daily Cardinal, tech leaders Jim Thompson, Mike Trigg and Allen Dines reflect on how AI has shaped ...

Bloomington pilot uses AI and genetic testing to detect familial hypercholesterolemia, a hidden cause of high cholesterol and heart risks in families.

AI-driven oculomics is transforming eye scans into powerful tools for detecting heart, brain, and metabolic health risks ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the next five years. Key factors driving this growth include the increasing ...

Explore best quotes Becker 8217 AI from Becker's CEO + CFO Roundtable highlighting healthcare leaders on AI's impact and future in care delivery.

Algorithmic crimes refer to crimes that are either influenced or enabled by algorithms. Algorithms determine what we see ...